Clinical Outcomes of Patients With Intermediate-To-High-Risk Follicular Lymphoma (Fl) in the Gallium Phase Iii Study

Hematological Oncology - United Kingdom
doi 10.1002/hon.56_2631
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Follicular Lymphoma (FL)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Immunochemotherapy With Obinutuzumab or Rituximab in Previously Untreated Follicular Lymphoma in the Randomised Phase Iii Gallium Study: Analysis by Chemotherapy Regimen

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Assessment Index of Clinical Transformation From Follicular Lymphoma (Fl) to Diffuse Large B-Cell Lymphoma (Dlbcl) in the Rituximab Era

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Risk of Secondary Hematological Malignancy in Patients With Follicular Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Gallium 68 PSMA-11 PET/MR Imaging in Patients With Intermediate- Or High-Risk Prostate Cancer

Radiology
Nuclear MedicineRadiologyImaging
2018English

Polatuzumab Vedotin (Pola) + Obinutuzumab (G) + Lenalidomide (Len) in Patients (Pts) With Relapsed/Refractory (R/R) Follicular Lymphoma (Fl): Phase Ib/Ii Interim Analysis

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Stratification of Patients With Follicular Lymphoma

2012English

Bendamustine and Rituximab in Elderly Patients With Low-Tumour Burden Follicular Lymphoma. Results of the LYSA Phase II BRIEF Study

British Journal of Haematology
Hematology
2018English

A Retrospective Study on the Management of Patients With Rituximab Refractory Follicular Lymphoma

British Journal of Haematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy